Despite past failures, Denali's extensive pipeline and solid financial runway make it a compelling buy at current low stock ...

This paper reports important findings on giant organelle complexes containing endosomes and lysosomes (termed endosomal-lysosomal organelles form assembly structures [ELYSAs]) present in mouse oocytes ...

近日，SCIENCE CHINA Life Sciences 在线发表中国科学院昆明植物研究所郝小江研究员团队题为“Isowalsuranolide targets TrxR1/2 and triggers lysosomal biogenesis ...

Charles Schwab Investment Management Inc. grew its holdings in shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) ...

Alternative splicing (AS) of pre-mRNA plays a crucial role in tissue-specific gene regulation, with disease implications due to splicing defects. Predicting and manipulating AS can therefore uncover ...

Sohn Hearts & Minds, was held in Adelaide resulting in the donation of $1.4 million towards South Australian medical ...

Stoke Therapeutics, Inc. is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen ...

an ultra-rare neurodegenerative lysosomal storage disorder. The company has collaboration and license agreement with Commave Therapeutics SA to develop, manufacture and commercialize the company ...

Dr Anup Rawool, Consultant in Clinical and Cancer Genetics at Sahyadri Hospitals, Pune, discusses innovative therapies and ...

After hours: March 19 at 4:05:09 PM EDT Loading Chart for DNLI ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc.

Investment analysts at Zacks Research issued their FY2027 earnings per share estimates for shares of Denali Therapeutics in a ...